The protein levels of the activated cleaved fragments of caspase-8 and caspase-9, which are the cascade initiators of caspase cell death, increased in CRC cells under ezetimibe treatment, as well as activated caspase-3, the apoptotic executioner (Figures 4A, B). This evidence concerns the gene CASP9 and colorectal carcinoma.